Castle Biosciences Inc (CSTL)

$CSTL this stock pisses me off

$CSTL 52 week low is IMMINENT

$CSTL 4 years and 4 melanoma surgeries/lab tests later they still can't get paid by my phenomenal insurance company without my f'ing help in signing an appeal request form. The price chart has been a POS the entire time and yet I keep watching and wondering when this important genetic information breakthru is ever going to justify an investment...

$CSTL what is going on with this price action?

$CSTL FDA Grants Innovative Device Designation to Castle Biosciences' DecisionDx®-Melanoma Test

$CSTL This recent downturn makes me think.....

$CSTL Terrible stock, bought several years ago and lost big time despite rosey ($90) forecasts. Terrible short or long hold. Get out and don't do business with this mismanaged company.

$CSTL $50😉

$CSTL This will be above $20 before ER. Hugely undervalued.

$CSTL Revenues will soon be higher than market cap. Undervalued!!!!!

$CSTL undervalued company

$CSTL good news. Today speculation

$CSTL is expanding into atopic dermatitis diagnostics through a new partnership with SciBase. The goal: develop a test to predict AD flares before symptoms appear. Aimed at a U.S. patient base of up to 24M. #CastleBiosciences https://prismmarketview.com/castle-biosciences-expands-into-atopic-dermatitis-diagnostics-with-new-scibase-partnership/

$CSTL Let's go MaetSOLD it's poking it's head up, flail away at the printer and sell those free shares.

$CSTL real value $50👍

$CSTL ✅ Healthcare - Small Cap - F-Score: 8/9 👑 Analysts: 8x buy rating 👨‍🔬 Intrinsic Value Potential: Excellent 💎 RSI: 35.07 (oversold bullish) 📊🐂 Highest Analysts Price Target: $40.00 (150% above Price) 🌟 Range (12m) $15.45 - $35.84 💰 Positive Free Cash Flow: Yes 🏧 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/CSTL/new-data-at-asco-2025-affirms-decision-dx-melanoma-s-ability-to-41kn1j62bobj.html

$CSTL The more it goes down, the more chance there will be to increase your position before the rise. I hope it will go to $10

$CSTL I'll wait until $10 to lower the average even though I don't think it will get there

$CSTL this fell to mid-teens around the same time last year and was at $30+ by late summer. Fundamentals are even better now, I expect history to repeat itself

$CSTL ✅ Healthcare - mid cap - 0.70x relative volume F-Score: 8/9 🏦👑 Analysts: 8x buy rating 👨‍🔬 Intrinsic Value Potential: Good 💎 RSI: 35.64 (oversold bullish) 📊🐂 Analysts Price Target: $37.75 - $44.00 (107% - 155% above Price) 🌟 Range (12m) $15.70 - $35.84 💰 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/CSTL/real-world-study-confirms-long-term-performance-of-decision-dx-um-th2em3357yg7.html